Favipiravir and/or nitazoxanide: a randomized, double-blind, placebo-controlled trial of early therapy in COVID-19 in health workers, their household members, and patients treated at IMSS (FANTAZE) (vol 23, 583, 2022)Tania A. Smith,Carlos Hoyo-Vadillo,Akosua Agyeman Adom,Liliana Favari-Perozzi,Silke Gastine,Hakim-Moulay Dehbi,Beatriz Villegas-Lara,Eduardo Mateos,Yessica Sara Perez Gonzalez,Maria D. Navarro-Gualito,Alejandra S. Cruz-Carbajal,Miguel A. Cortes-Vazquez,Carolina Bekker-Mendez,Charmina Aguirre-Alvarado,Gisela Aguirre-Gil,Lucero Delgado-Pastelin,Andrew Owen,David Lowe,Joseph Standing,Jorge EscobedoTRIALS(2023)引用 0|浏览8暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要